These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26565594)

  • 1. Casein kinases as potential therapeutic targets.
    Cozza G; Pinna LA
    Expert Opin Ther Targets; 2016; 20(3):319-40. PubMed ID: 26565594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein kinase: the triple meaning of a misnomer.
    Venerando A; Ruzzene M; Pinna LA
    Biochem J; 2014 Jun; 460(2):141-56. PubMed ID: 24825444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule modulators targeting protein kinase CK1 and CK2.
    Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H
    Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.
    Perez DI; Gil C; Martinez A
    Med Res Rev; 2011 Nov; 31(6):924-54. PubMed ID: 20577972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins.
    Cozza G; Salvi M; Banerjee S; Tibaldi E; Tagliabracci VS; Dixon JE; Pinna LA
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1718-26. PubMed ID: 25936777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase activity in etiolated Cucumis sativus cotyledons.
    Vidal D; Alvarez-Flórez F; Simón E
    Plant Biol (Stuttg); 2010 Jan; 12(1):134-44. PubMed ID: 20653896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.
    Stavenuiter F; Gale AJ; Heeb MJ
    FASEB J; 2013 Jul; 27(7):2918-25. PubMed ID: 23580615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fam20C is under the control of sphingolipid signaling in human cell lines.
    Cozza G; Salvi M; Tagliabracci VS; Pinna LA
    FEBS J; 2017 Apr; 284(8):1246-1257. PubMed ID: 28236661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase CK2 inhibitors: a patent review.
    Cozza G; Pinna LA; Moro S
    Expert Opin Ther Pat; 2012 Sep; 22(9):1081-97. PubMed ID: 22908959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Golgi 'casein kinase' Fam20C is a genuine 'phosvitin kinase' and phosphorylates polyserine stretches devoid of the canonical consensus.
    Cozza G; Moro E; Black M; Marin O; Salvi M; Venerando A; Tagliabracci VS; Pinna LA
    FEBS J; 2018 Dec; 285(24):4674-4683. PubMed ID: 30387551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.
    Qin Z; Wang P; Li X; Zhang S; Tian M; Dai Y; Fu L
    Mol Biosyst; 2016 Jun; 12(7):2108-18. PubMed ID: 27113542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the proteins of the extracellular matrix of mineralized tissues by casein kinase-like activity.
    Veis A; Sfeir C; Wu CB
    Crit Rev Oral Biol Med; 1997; 8(4):360-79. PubMed ID: 9391750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving effective and selective CK1 inhibitors through structure modification.
    Du C; Yang H; Feng F; Liu W; Chen Y; Sun H
    Future Med Chem; 2021 Mar; 13(5):505-528. PubMed ID: 33438471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R; Cochet C
    Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2 inhibition as a pharmacological strategy.
    Borgo C; Ruzzene M
    Adv Protein Chem Struct Biol; 2021; 124():23-46. PubMed ID: 33632467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
    Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
    Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat liver Golgi apparatus contains a protein kinase similar to the casein kinase of lactating mammary gland.
    Lasa M; Marin O; Pinna LA
    Eur J Biochem; 1997 Feb; 243(3):719-25. PubMed ID: 9057837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.